Teza Capital Management’s Sage Therapeutics SAGE Stock Holding History

Teza Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,589	Closed	-$62.9K	–	570
2024 Q4	$62.9K	Sell	11,589 -2,180	-16%	-$13.3K	0.01%	464
2024 Q3	$99.4K	Buy	13,769 +1,592	+13%	+$14.6K	0.01%	571
2024 Q2	$132K	Buy	+12,177	New	+$156K	0.02%	544
2021 Q3	–	Sell	-11,562	Closed	-$657K	–	560
2021 Q2	$657K	Buy	11,562 +6,400	+124%	+$452K	0.11%	253
2021 Q1	$386K	Buy	+5,162	New	+$423K	0.08%	327
2020 Q4	–	Sell	-5,254	Closed	-$321K	–	418
2020 Q3	$321K	Sell	5,254 -10,258	-66%	-$520K	0.19%	196
2020 Q2	$645K	Buy	+15,512	New	+$563K	0.14%	224

Other funds holding SAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return